CAN risk in diabetes reduced with intensive control of blood glucose and blood pressure

BOSTON – (December 16, 2020) – Intensive interventions to reduce blood glucose and blood pressure levels in type 2 diabetes reduce the risk of developing cardiovascular autonomic neuropathy (CAN), a frequent but underdiagnosed complication of diabetes that can be life-threatening. In a study led by Alessandro Doria, MD, PhD, MPH, from the Joslin Diabetes Center…

Details

Press-exclusive Q&A sessions with top speakers at SfN Global Connectome: A Virtual Event

The world’s largest neuroscience community will virtually gather January 11-13, 2021 to share the latest developments in brain research. SfN Global Connectome: A Virtual Event, the brand-new digital gathering hosted by the Society for Neuroscience, will feature thousands of presentations on brain function, health, and disease, covering topics such as empathy, sleep, gut-brain interactions, machine…

Details

COVID-19 spread increases when UV levels decrease

Natural variations in ultraviolet radiation influence the spread of COVID-19, but the influence is modest compared to preventive measures such as physical distancing, mask wearing, and quarantine, according to new research from Harvard University. “Understanding the potential seasonality of COVID-19 transmission could help inform our response to the pandemic in the coming months,” said Jonathan…

Details

Oral hormone therapy shown to significantly alter metabolome of menopausal women

Groundbreaking research led by a team of scientists including a University of Massachusetts Amherst biostatistician shows that oral hormone therapy (HT) significantly alters the metabolome of postmenopausal women. This finding, which examined blood specimens from the landmark Women’s Health Initiative (WHI) study, may help explain the disease risks and protective effects associated with different regimens…

Details

Experimental vaccine can counter dangerous effects of synthetic cannabinoids

LA JOLLA, CA–Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat. In a new study, Scripps Research scientists have devised a way to deactivate these designer drugs after they’ve been administered–offering a potential path for treating addiction and…

Details